[Common name] Nateglinide Tablets

[Ingredients] The major ingredient is nateglinide.

[Indication] The product can be independently used by those suffering type 2 diabetes mellitus who fail to effectively control hyperglycemia by diet control and exercise, also applicable for those who fail to effectively control hyperglycemia by using metformin. It can be used in combination with metformin, while cannot replace it. The product is not applicable for those suffering type 2 diabetes mellitus and having little effectiveness by using sulfonylureas hypoglycemic drugs.

[Specification] 30mg

[Usage and Dosage] Take orally. For adult, generally, 60∼120mg (2-4 tablets) at each time, thrice a day, taking it 1-15 min prior to a meat. It is recommended to take it from small dosage, and regularly detect HbAlc or blood sugar within 1-2h after a meal so as to adjust the dosage.

[Package] Aluminum plastic packaging; (1) 24 tablets per box, (2) 48 tablets per box

[Expiry Date] 36 months (Tentative)

[Executive Standard] State Food and Drug Administration, National Drug Standard, YBH17582004

[Approval Document Number] G (J) H20041649